European Archives - Page 50 of 1301 - European Medical Journal

Hypnosis

Hypnosis Improves Patient Mask Tolerance in Emergencies

Hypnosis can enhance comfort and clinical efficacy of non-invasive ventilation masks, reducing sedation needs and distress in acute respiratory failure patients.

Migraine

Candesartan Proven Effective for Migraine Prevention

Trial shows candesartan cuts migraine days and is well tolerated. Read more to learn about this promising prevention therapy.

Type 1 Diabetes

High-Dose Metformin Aids Weight and Lipid Control in Adolescent Type 1 Diabetes

Learn how high-dose metformin improves BMI, insulin needs, and LDL-C in adolescents with T1D.

Baked milk

Baked Milk Improves Tolerance in Cow’s Milk Allergy

Discover a study showing how baked milk intake accelerates cow’s milk allergy resolution, boosting safety and tolerance in young children.

MASLD Outcomes Improved with Tirzepatide and Semaglutide

For individuals with MASLD and Type 2 diabetes, these findings suggest that tirzepatide and semaglutide could play a significant role in reducing liver-related complications

LLMs Can Assess Accuracy of AI-based Randomized Controlled Trials

LLMs show strong potential in assessing AI trial reporting, with GPT-4 models performing best against CONSORT-AI standards.

Osteopathy in Practice

Step into the world of modern osteopathy with Sandy Phanor in this podcast series. From busting myths in a quickfire Q&A to exploring the emotional side of healing, Phanor shares real-world insights from the clinic.

Women’s Eggs Resist Aging at the Mitochondrial Level

Discover a study revealing that human egg cells stay genetically stable with age, resisting mitochondrial DNA mutations and preserving fertility potential.

Broadly Protective SARS Vaccine Could Save Lives in Future Pandemics

A broadly protective sarbecovirus vaccine could slow outbreaks, reduce deaths and give health systems critical time in future pandemics, new research suggests.

cardiotoxic

Cardiotoxic Gene Marker Identified in Childhood Cancer Survivors

Cardiotoxic treatments in survivors link to gene markers, with new research highlighting NFE2L2 as a predictive biomarker.